Forte Biosciences (FBRX) Change in Acquisitions & Divestments (2016 - 2025)

Forte Biosciences' (FBRX) quarterly Change in Acquisitions & Divestments came in at $36.4 million in Q1 2025, up 3634900.0% on a QoQ basis from $1000.0 in Q4 2023.

Forte Biosciences (FBRX) Change in Acquisitions & Divestments (2016 - 2025) Analysis & Trends

Forte Biosciences (FBRX) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $36.4 million in Q1 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $36.4 million in Q1 2025; TTM through Dec 2025 was $36.4 million, a 185.7% increase from a year earlier, with the FY2025 full-year figure at $36.4 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q1 2025 stood at $36.4 million, up from $1000.0 in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for FBRX reached as high as $36.4 million in Q1 2025 and fell as low as $1000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn
10 Forte Biosciences 1.36 Bn 1.31 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 36.35 Mn
Mar 31, 2025 36.35 Mn
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Mar 31, 2020 12.72 Mn
Mar 31, 2020 12.72 Mn
Dec 31, 2019 16.84 Mn
Dec 31, 2019 16.84 Mn
Sep 30, 2019 27.69 Mn
Sep 30, 2019 27.69 Mn
Jun 30, 2019 21.11 Mn
Jun 30, 2019 21.11 Mn
Mar 31, 2019 27.84 Mn
Mar 31, 2019 27.84 Mn
Dec 31, 2018 19.34 Mn
Dec 31, 2018 19.34 Mn
Sep 30, 2018 22.73 Mn
Sep 30, 2018 22.73 Mn
Jun 30, 2018 17.37 Mn
Jun 30, 2018 17.37 Mn